GGrantIndex
← Leaderboards

Xin Qi

Case Western Reserve University

$14,172,824
Attributed
$14,463,407
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,463,407 · 10

By mechanism

R01$11,022,077 · 6
RF1$2,136,033 · 1
R21$888,401 · 2
R56$416,896 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNeuronsCellsMitochondriaMolecularNeuropathologyNerve DegenerationProteomicsImpairmentBrainBehavioralMediatingPathogenesisAnimal ModelProteinsPathologicBiochemicalS DiseasePeptidesMutantPathologyCell Culture TechniquesEventSymptoms

Grant awards (25)

Regulation of ATAD3A in TDP43-associated ALS/FTD$737,720
R01 · FY2025 · NS · contact PI
Regulation of CHCHD6 in Alzheimer's disease$697,772
R01 · FY2025 · AG · contact PI
Mechanism of white matter pathology in Alzheimer's disease$595,347
R01 · FY2025 · AG · contact PI
Mechanism of white matter pathology in Alzheimer's disease$607,498
R01 · FY2024 · AG · contact PI
Role of brain lipid metabolism in Alzheimer's disease$603,824
R01 · FY2024 · AG · contact PI
Mechanism of white matter pathology in Alzheimer's disease$607,498
R01 · FY2023 · AG · contact PI
Proteostasis dysregulation and alpha-synuclein$604,470
R01 · FY2023 · NS · contact PI
Role of brain lipid metabolism in Alzheimer's disease$603,824
R01 · FY2023 · AG · contact PI
Regulation of CHCHD6 in Alzheimer's disease$2,136,033
RF1 · FY2022 · AG · contact PI
Mechanism of white matter pathology in Alzheimer's disease$607,498
R01 · FY2022 · AG · contact PI
Proteostasis dysregulation and alpha-synuclein$604,470
R01 · FY2022 · NS · contact PI
Role of brain lipid metabolism in Alzheimer's disease$603,824
R01 · FY2022 · AG · contact PI
Proteostasis dysregulation and alpha-synuclein$604,470
R01 · FY2021 · NS · contact PI
Role of brain lipid metabolism in Alzheimer's disease$603,824
R01 · FY2021 · AG · contact PI
Proteostasis dysregulation and alpha-synuclein$603,869
R01 · FY2020 · NS · contact PI
Role of brain lipid metabolism in Alzheimer's disease$602,574
R01 · FY2020 · AG · contact PI
Mitochondrial biomarkers in Huntington's disease$452,526
R21 · FY2019 · NS · contact PI
Mitochondrial quality control and alpha-synuclein$416,896
R56 · FY2019 · NS · contact PI
Dynamin-related protein 1, neurodegeneration and Huntington's disease$346,719
R01 · FY2018 · NS · contact PI
Dynamin-related protein 1, neurodegeneration and Huntington's disease$346,719
R01 · FY2017 · NS · contact PI
Dynamin-related protein 1, neurodegeneration and Huntington's disease$346,719
R01 · FY2016 · NS · contact PI
Dynamin-related protein 1, neurodegeneration and Huntington's disease$346,719
R01 · FY2015 · NS · contact PI
Generating iPSC-derived Neurons to Explore Formation & Inhibition of Human Prions$198,125
R21 · FY2015 · NS
Dynamin-related protein 1, neurodegeneration and Huntington's disease$346,719
R01 · FY2014 · NS · contact PI
Generating iPSC-derived Neurons to Explore Formation & Inhibition of Human Prions$237,750
R21 · FY2014 · NS